Semantic Scholar uses AI to extract papers important to this topic.
Abstract: Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly being used for the treatment of… Expand Lixisenatide (AVE0010) is a once-daily glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes… Expand This was a subanalysis of Japanese patients included in the glucagon‐like peptide‐1 receptor agonist AVE0010 in patients with… Expand AbstractLixisenatide (AVE0010) is a once-daily glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2… Expand
Diabet. Med. 27, 1024–1032 (2010)
We recently showed that insulin analogues exhibit a beta-cell protective function. The aim of this study was to test if the anti… Expand Glucagon-like peptide-1 (GLP-1) is an incretin hormone that is secreted by cells of the lower gastro-intestinal tract following… Expand